References
- Monteleone G, Moscardelli A, Colella A, et al. Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features. Autoimmun Rev. 2023; 22(10):103410.
- Ortega MA, García-Montero C, Fraile-Martinez O, et al. Immune-mediated diseases from the point of view of psychoneuroimmunoendocrinology. Biology (Basel). 2022; 11(7):973.
- Hysa E, Lercara A, Cere A, et al. Temporomandibular disorders in immune-mediated rheumatic diseases of the adult: A systematic review. Semin Arthritis Rheum. 2023; 61:152215.
- Rahman P, Inman RD, El-Gabalawy H, et al. Pathophysiology and pathogenesis of immune-mediated inflammatory diseases: commonalities and differences. J Rheumatol Suppl. 2010; 85:11-26.
- Ginard-Vicens D, Tornero-Molina J, Fernández-Fuente-Bursón L, et al. Patient preferences in chronic immune-mediated inflammatory diseases potentially treated with biological drugs: discrete choice analysis using real-world data analysis. Expert Rev Pharmacoecon Outcomes Res. 2023; 23(8):959-965.
- Agrawal M, Spencer EA, Colombel JF, et al. Approach to the management of recently diagnosed inflammatory bowel disease patients: A user’s guide for adult and pediatric gastroenterologists. Gastroenterology. 2021; 161(1):47-65.
- Guilliams TG, Weintraub J. Implementing Personalized Dietary Interventions for Immune-Mediated Inflammatory Diseases. Integr Med (Encinitas). 2023; 22(5):18-26.
- Brown P, Pratt AG, Hyrich KL. Therapeutic advances in rheumatoid arthritis. BMJ. 2024;384: e070856.
- Patel JP, Konanur Srinivasa NK, Gande A, et al. The role of biologics in rheumatoid arthritis: a narrative review. Cureus. 2023; 15(1):e33293.
- Honap S, Jairath V, Danese S, et al. Navigating the complexities of drug development for inflammatory bowel disease. Nat Rev Drug Discov. 2024 May 22.
- Shellard EM, Rane SS, Eyre S, et al. Functional genomics and insights into the pathogenesis and treatment of psoriasis. Biomolecules. 2024;14(5): 548.
- Vebr M, Pomahaþová R, Sýkora J, et al. A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis. Biomedicines. 2023; 11(12):3229.
- Zhou Y, Cao T, Li Z, et al. Fibroblasts in immune-mediated in-flammatory diseases: The soil of inflammation. Clin Immunol. 2024; 258:109849.
- Schett G, McInnes IB, Neurath MF. Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N Engl J Med. 2021; 385(7):628-639.
- Das UN. Acetylcholinesterase and butyrylcholinesterase as markers of low-grade systemic inflammation. Ann Hepatol. 2012; 11(3):409-4011.
- Milstoc M. Cholinesterase activity in patients with rheumatoid arthritis. Am J Clin Pathol. 1970 Apr;53(4):452-7. doi: 10.1093/ajcp/53.4.452.
- Wang DW, Zhou RB, Yao YM. Role of cholinergic anti-inflammatory pathway in regulating host response and its interventional strategy for inflammatory diseases. Chin J Traumatol. 2009; 12(6):355-364.
- Abdullah RG, Eassa SH, Mohammad FK. Plasma cholinesterase activity in patients with rheumatoid arthritis and toxoplasmosis. Cureus. 2023; 15(12):e50979.
- Weber BN, Garshick M, Abbate A, et al. Acute cardiovascular complications of immune-mediated systemic inflammatory diseases. Eur Heart J Acute Cardiovasc Care. 2023; 12(11):792-801.
- Nune A, Durkowski V, Pillay SS, et al. New-onset rheumatic immune-mediated inflammatory diseases following SARSCoV-2 vaccinations until May 2023: A systematic review. Vaccines (Basel). 2023; 11(10): 1571.
- Zhang H, Qiao W, Liu R, et al. Development and validation of a novel biomarker panel for Crohn’s disease and rheumatoid arthritis diagnosis and treatment. Aging (Albany NY). 2024; 16(6):5224-5248.
- Kasim HF, Salih HM, Eassa SH. Adherence to biologic drugs among patients with immune mediated inflammatory diseases in Duhok governorate. Duhok Med J. 15Aug.2020; 14(1): 63-66.
- Kasim HF, Salih HM, Eassa SH. Detection of anti-infliximab antibodies and identifying factors affecting their occurrence using Elisa method among patients with immune-mediated inflammatory diseases. Ind J Foren Med Toxicol. 2021; 15(3):3047-3058.
- Odisho SK, Mohammad FK. Blood cholinesterase activities and oxidative stress status among farmworkers using pesticides in Duhok, KRG, Iraq. J Ideas Health. 2022; 5(4):786-793.
- Mohammad FK. Clarifying an electrometric method for determining blood cholinesterase activity: a scientific letter. Asia Pac J Med Toxicol. 2022; 11(1):30-32.
- Hammer Ø, Harper DAT, Ryan PD. PAST: paleontological statistics software package for educaton and data anlysis. Palaeontol Electron. 2001; 4(1):1.
- Mukaka MM. Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012; 24(3):69-71.
- GBD 2019 IMID Collaborators. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. EClinicalMedicine. 2023; 64:102193.
- Wójcik P, GĊgotek A, Žarkoviü N, et al. Oxidative stress and lipid mediators modulate immune cell functions in autoimmune diseases. Int J Mol Sci. 2021; 22(2):723.
- Wang W, Huang M, Ge W, et al. Identifying serum metabolite biomarkers for autoimmune diseases: a two-sample Mendelian randomization and meta-analysis. Front Immunol. 2024; 15:1300457.